Diabetes Kongress 2019
zur Liste
Dr. Richard Klar
Secarna pharmaceuticals GmbH & Co. KG Germany
  • Vortrag Targeting the maladaptive ER-stress mediator Chop using LNAplus™ antisense-oligonucleotides in diabetic nephropathy Speaker
    Datum: 30.05.2019 , Zeit: 11:30 | Thema: Typ-2-Diabetes
    Details